Pfizer says its COVID pill reduces risk of hospitalisation,

Pfizer’s anti-COVID pill PAXLOVID reduced the risk of hospitalisation or death for any cause by around 89 percent compared to placebo in patients treated within 5 days of onset of symptoms.

Related Keywords

, Albert Bourla , Pfizer , Drug Administration , Protease Inhibition , Emergency Use Authorisation , Pfizer Covid 19 Pill , Pfizer Anti Covid Pill , Paxlovid , Pfizer Paxlovid , Paxlovid Covid 19 Pill , Paxlovid Pill , Axlovid Effects , Axlovid Side Effects , Pfizer Ceo , Pfizer Chairman , Us Food And Drug Administration , S Fda ,